Correlation Between NewAmsterdam Pharma and Bridger Aerospace

Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Bridger Aerospace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Bridger Aerospace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NewAmsterdam Pharma and Bridger Aerospace Group, you can compare the effects of market volatilities on NewAmsterdam Pharma and Bridger Aerospace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Bridger Aerospace. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Bridger Aerospace.

Diversification Opportunities for NewAmsterdam Pharma and Bridger Aerospace

0.34

Correlation Coefficient

NewAmsterdam Pharma  Bridger Aerospace

Weak diversification

The 3 months correlation between NewAmsterdam and Bridger is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Bridger Aerospace Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bridger Aerospace and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Bridger Aerospace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bridger Aerospace has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Bridger Aerospace go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and Bridger Aerospace

Assuming the 90 days horizon NewAmsterdam Pharma is expected to generate 2.05 times less return on investment than Bridger Aerospace. But when comparing it to its historical volatility, NewAmsterdam Pharma is 1.56 times less risky than Bridger Aerospace. It trades about 0.08 of its potential returns per unit of risk. Bridger Aerospace Group is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  5.53  in Bridger Aerospace Group on May 6, 2025 and sell it today you would earn a total of  2.26  from holding Bridger Aerospace Group or generate 40.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.41%
Values	Daily Returns

NewAmsterdam Pharma  vs.  Bridger Aerospace Group

NewAmsterdam Pharma

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, NewAmsterdam Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Bridger Aerospace

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bridger Aerospace Group are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Bridger Aerospace showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NewAmsterdam Pharma and Bridger Aerospace

The main advantage of trading using opposite NewAmsterdam Pharma and Bridger Aerospace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Bridger Aerospace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bridger Aerospace will offset losses from the drop in Bridger Aerospace's long position.

The idea behind NewAmsterdam Pharma and Bridger Aerospace Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.